Literature DB >> 2968843

Subclass specificity of the Fc receptor for human IgG on K562.

M S Chiofalo1, G Teti, J M Goust, R Trifiletti, M F La Via.   

Abstract

The erythroleukemic cell line K562 bears a 40-kDa Fc receptor (Fc gamma RII) serologically related to and with a similar molecular weight as the Fc gamma R present on a broad range of leukocytes. The human IgG subclass specificity of the Fc gamma R on K562 was investigated using IgG aggregates of defined size, obtained from purified human myeloma proteins. The monoclonal antibody IV.3, which reacts with the Fc gamma RII present on various cell types, totally prevented binding of 125I-IgG2 trimers to K562. Experiments with radiolabeled IgG2 trimers showed that K562 cells bound a mean of 156,764 +/- 9895 molecules per cell with an association constant (Ka) of 1.8 +/- 0.7 X 10(8) M-1. Similar results were obtained with IgG3 oligomers. IgG3 and IgG2 trimers were about two- to threefold more effective in inhibiting binding of 125I-IgG2 trimers to K562 than IgG1 and IgG4 trimers. These results were confirmed by inhibition experiments using IgG monomers. The subclass specificity of the Fc gamma RII on K562 (i.e., IgG2 = IgG3 greater than IgG1 = IgG4) is quite distinct from the one reported for the Fc gamma RI and III of human cells (i.e., IgG1 = IgG3 greater than IgG4 and IgG2).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968843     DOI: 10.1016/0008-8749(88)90321-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum.

Authors:  William G Valiant; Joseph J Mattapallil
Journal:  J Vis Exp       Date:  2018-04-10       Impact factor: 1.355

2.  Comodulation of Dengue and Chikungunya Virus Infection During a Coinfection Scenario in Human Cell Lines.

Authors:  Debjani Taraphdar; Bharati Singh; Sabyasachi Pattanayak; Avula Kiran; Poornima Kokavalla; Mohd Faraz Alam; Gulam Hussain Syed
Journal:  Front Cell Infect Microbiol       Date:  2022-04-28       Impact factor: 6.073

3.  An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.

Authors:  Yan Guo; Wenhui He; Huihui Mou; Lizhou Zhang; Jing Chang; Shoujiao Peng; Amrita Ojha; Rubens Tavora; Mark S Parcells; Guangxiang Luo; Wenhui Li; Guocai Zhong; Hyeryun Choe; Michael Farzan; Brian D Quinlan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

4.  A novel PAN/apple domain-containing protein from Toxoplasma gondii: characterization and receptor identification.

Authors:  Haiyan Gong; Kyousuke Kobayashi; Tatsuki Sugi; Hitoshi Takemae; Hitomi Kurokawa; Taisuke Horimoto; Hiroomi Akashi; Kentaro Kato
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

5.  Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques.

Authors:  Jeffy George; William G Valiant; Mary J Mattapallil; Michelle Walker; Yan-Jang S Huang; Dana L Vanlandingham; John Misamore; Jack Greenhouse; Deborah E Weiss; Daniela Verthelyi; Stephen Higgs; Hanne Andersen; Mark G Lewis; Joseph J Mattapallil
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.

Authors:  Brian D Quinlan; Wenhui He; Huihui Mou; Lizhou Zhang; Yan Guo; Jing Chang; Shoujiao Peng; Amrita Ojha; Rubens Tavora; Mark S Parcells; Guangxiang Luo; Wenhui Li; Guocai Zhong; Hyeryun Choe; Michael Farzan
Journal:  bioRxiv       Date:  2020-11-18

7.  Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry.

Authors:  Dhiraj Mannar; Karoline Leopold; Sriram Subramaniam
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.